Exclusive Interviews

In part 8, the conclusion of this Exclusive Interview, John Buse talks with Diabetes in Control Publisher Steve Freed about the good and bad effects of using SGLT2 for patients who have type 1.

Lisa M. Latts MD, MSPH, MBA, FACP is Deputy Chief Health Officer for IBM Watson Health. She is a national leader in health care quality and has nearly 20 years’ experience in health care delivery working to improve lives for patients.  She has worked as a health insurance executive, a consultant and for one of the nation’s leading academic medical centers helping to deliver high quality care to its faculty and employees. She is currently helping IBM Watson Health bring cognitive computing and machine learning to advance the idea of Value-Based Care and help solve the pressing problems that physicians, employers and payers are facing.

In this Exclusive Interview transcript, Lisa Latts talks with Diabetes in Control Publisher Steve Freed during the ADA 2018 convention in Orlando about applications of Watson AI for diabetes care and the benefits for healthcare providers and patients who have diabetes and are taking diabetes medications.

In this Exclusive Interview, Lisa Latts talks with Diabetes in Control Publisher Steve Freed during the ADA 2018 convention in Orlando about Watson AI and what it can offer to healthcare providers and patients who have diabetes and are taking diabetes medications.

In part 1 of this Exclusive Interview, Lisa Latts talks with Diabetes in Control Publisher Steve Freed about the work done in partnership with the ADA regarding findings among patients with diabetes and their use of medications.

In part 2 of this Exclusive Interview, Lisa Latts explains the process behind the artificial intelligence Watson in a conversation with Diabetes in Control Publisher Steve Freed.

In part 3 of this Exclusive Interview, Lisa Latts talks with Diabetes in Control Publisher Steve Freed about the personalization of medicine as the future of diabetes care.

In part 4 of this Exclusive Interview, Lisa Latts talks with Diabetes in Control Publisher Steve Freed about the genesis of Watson and the work currently in the pipeline.

In part 5 of this Exclusive Interview, Lisa Latts talks with Diabetes in Control Publisher Steve Freed about the findings from the cardiovascular study for use in Watson.

In part 6 of this Exclusive Interview, Lisa Latts talks with Diabetes in Control Publisher Steve Freed about her desire to make the healthcare system work more effectively and improve the practice of medicine.